Ferring Sues Actavis Over Generic Blood Loss Drug
Global pharmaceutical group Ferring BV has accused a subsidiary of New Jersey-based Actavis Inc. of unlawfully making and selling a generic form of its blood loss treatment drug Lysteda before Ferring's...To view the full article, register now.
Already a subscriber? Click here to view full article